Publications by authors named "Kathryn Bland"

Article Synopsis
  • CycloAnt is an opioid peptide effective in pain relief (antinociception) with fewer side effects when tested systemically in mice.
  • It shows stability against degradation in mouse serum and is resistant to metabolism in the liver, indicating a long-lasting effect in the body.
  • CycloAnt successfully crosses the blood-brain barrier, aided by its flexible structure that changes shape depending on its environment, enhancing its ability to penetrate the brain.
View Article and Find Full Text PDF

Background: A growing body of preclinical studies report that preconceptional experiences can have a profound and long-lasting impact on adult offspring behavior and physiology. However, less is known about paternal drug exposure and its effects on reward sensitivity in the next generation.

Methods: Adult male rats self-administered morphine for 65 days; controls received saline.

View Article and Find Full Text PDF

Key targets of both the therapeutic and abused properties of opioids are μ-opioid receptors (MORs). Despite years of research investigating the biochemistry and signal transduction pathways associated with MOR activation, we do not fully understand the cellular mechanisms underlying opioid addiction. Given that addictive opioids such as morphine, oxycodone, heroin, and fentanyl all activate MORs, and current therapies such as naloxone and buprenorphine block this activation, the availability of tools to mechanistically investigate opioid-mediated cellular and behavioral phenotypes are necessary.

View Article and Find Full Text PDF

Selective kappa opioid receptor (KOR) agonists are promising antipruritic agents and analgesics. However, clinical development of KOR agonists has been limited by side effects, including psychotomimetic effects, dysphoria, and sedation, except for nalfurafine, and recently. CR845 (difelikefalin).

View Article and Find Full Text PDF